Goranci-Buzhala, G.* ; Mariappan, A.* ; Ricci-Vitiani, L.* ; Josipovic, N.* ; Pacioni, S.* ; Gottardo, M.* ; Ptok, J.* ; Schaal, H.* ; Callaini, G.* ; Rajalingam, K.* ; Dynlacht, B.D.* ; Hadian, K. ; Papantonis, A.* ; Pallini, R.* ; Gopalakrishnan, J.*
Cilium induction triggers differentiation of glioma stem cells.
Cell Rep. 36:109656 (2021)
Glioblastoma multiforme (GBM) possesses glioma stem cells (GSCs) that promote self-renewal, tumor propagation, and relapse. Understanding the mechanisms of GSCs self-renewal can offer targeted therapeutic interventions. However, insufficient knowledge of GSCs' fundamental biology is a significant bottleneck hindering these efforts. Here, we show that patient-derived GSCs recruit elevated levels of proteins that ensure the temporal cilium disassembly, leading to suppressed ciliogenesis. Depleting the cilia disassembly complex components is sufficient to induce ciliogenesis in a subset of GSCs via relocating platelet-derived growth factor receptor-alpha (PDGFR-α) to a newly induced cilium. Importantly, restoring ciliogenesis enabled GSCs to switch from self-renewal to differentiation. Finally, using an organoid-based glioma invasion assay and brain xenografts in mice, we establish that ciliogenesis-induced differentiation can prevent the infiltration of GSCs into the brain. Our findings illustrate a role for cilium as a molecular switch in determining GSCs' fate and suggest cilium induction as an attractive strategy to intervene in GSCs proliferation.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Brain Organoids ; Cell Cycle ; Cilium Checkpoint ; Confocal 3d Imaging ; Glioblastoma ; Invasion Assay ; Primary Cilium ; Tissue Clearing; Patient-derived Glioblastoma; Ciliogenesis; Identification; Temozolomide; Activation; Subtypes; Neurons; Aurora; Pdgfra; Growth
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2021
Prepublished im Jahr
HGF-Berichtsjahr
2021
ISSN (print) / ISBN
2211-1247
e-ISSN
2211-1247
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 36,
Heft: 10,
Seiten: ,
Artikelnummer: 109656
Supplement: ,
Reihe
Verlag
Cell Press
Verlagsort
50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Enabling and Novel Technologies
PSP-Element(e)
G-505293-001
Förderungen
SPP1935
Pharmacology and Bayer Graduate Program at the University of Cologne
AIRC
Deutsche Krebshilfe
Copyright
Erfassungsdatum
2021-10-13